Breaking Down Barriers to Biosimilar Access
November 26, 2025
With new approvals for its denosumab biosimilars, Biocon Biologics is working to close gaps in access across Europe. Blake Leitch shares how education, collaboration, and regulatory innovation can accelerate adoption and benefit more patients.
6 min read